	Differential impact of host-related factors on survival outcomes between IO+IO and IO+TKI in metastatic renal cell carcinoma: a multicenter retrospective study. Int J Clin Oncol Sugimoto K, Toyoda S, Inoki L, Mori K, Yanagisawa T, Tamura K, Nukaya T, Maenosono R, Morinaka H, Nishimura S, Bekku K, Komura K, Takahara K, Inamoto T, Azuma H, Fujita K, JK-FOOT study group. PMID: 42277542 [PubMed - as supplied by publisher]
	A lightweight ResNet50V2-ECA model for renal cell carcinoma grading: efficiency, calibration, and state-of-the-art performance. Sci Rep Alwateer M. PMID: 42277241 [PubMed - as supplied by publisher]
	Preventive Dental Strategies to Minimize Oral Health Complications After Renal Transplantation: A Systematic Review. Transplant Proc El Hennawy HM, El Hennawy MH, Safar O, Jaber TM, Aboalsamh GA, Awais M, Tawahri I, Balla ME, Almalki AH. PMID: 42276936 [PubMed - as supplied by publisher]
	How Will PSMAddition Impact the Management of Prostate Cancer? Eur Urol Focus Marulanda-Corzo V, Holmes AN, Giri VK, Osborne JR, Tagawa ST. PMID: 42276910 [PubMed - as supplied by publisher]
	Urethral Complications After Masculinizing Genital Gender-affirming Surgery. Eur Urol Focus Waterloos M, Vetterlein MW, Cocci A, Falcone M. PMID: 42276909 [PubMed - as supplied by publisher]
	Study Protocol of OLIGOPELVIS 2-GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate Cancer. Eur Urol Oncol Josset Q, Blanc-Lapierre A, Pigne G, Cartier L, Pasquier D, Ronchin P, Bera G, Hasbini A, Schipman B, Khalifa J, Sargos P, Quivrin M, Schick U, Mallet F, Laude C, Morand C, Loos G, Vaugier L, Zhou K, Mesgouez-Nebout N, Supiot S. PMID: 42276876 [PubMed - as supplied by publisher]
	Persistent increased risk of renal replacement therapy following COVID-19: a 2-year follow-up study in Japan using propensity score matching and inverse probability censoring weighting. BMJ Open Miyamori D, Fukuma S, Ikeda K, Haratake D, Yoshida S, Ito M. PMID: 42276811 [PubMed - in process]
	Surgery or radiotherapy for early-stage cancer study protocol for an emulated target trial of radical radiotherapy versus radical cystectomy, with either following neoadjuvant chemotherapy, for organ-confined muscle-invasive bladder cancer. BMJ Open Kagenaar E, Lugo-Palacios DG, Bromley H, Aggarwal A, Hutchings A, O'Neill S, Rachet B, Cresswell J, Choudhury A, Grieve R. PMID: 42276804 [PubMed - in process]
	Urine IRF4/PENK/PXDN Methylation Signatures Enable Machine Learning-Driven Bladder Cancer Detection and Microenvironment Dissection. Technol Cancer Res Treat He Y, Xie W, Chen W, Dai S, Wang X, Zhao X, Lei S, Zhu W, Qian Y, Feng J, Gong Z, Li J, Yang P, Xu X, Fei W, Zhang D, Cao Y, Jin J. PMID: 42276585 [PubMed - indexed for MEDLINE]
	Multivitamin Supplementation Mitigates Chronic Stress Induced Testicular Dysfunction by Restoring One-Carbon Metabolism, Redox Balance, and Spermatogenesis in Rats. Physiol Behav Ahmad M, Zoha Q, Zahid N, Naz N. PMID: 42276538 [PubMed - as supplied by publisher]
	The therapeutic potential of Puerarin on diabetic kidney disease: Focus on molecular mechanisms and future perspectives. Pharmacol Res Ma P, Gao Y, Wang H, Jiang X, Tang Y, Gong M, Gong J, Dong H, Su H. PMID: 42276397 [PubMed - as supplied by publisher]
	Molecular Mechanisms and Therapeutic Targets of Traditional Chinese Medicine Compounds in Renal Cell Carcinoma: A Comprehensive Narrative Review. J Ethnopharmacol Ye Z, Jia M, Tian X, Zhou B, Wang C, Lin H, Ma W, Dai R. PMID: 42276388 [PubMed - as supplied by publisher]
	Cisplatin-induced renal injury: ROS-mediated oxidative stress - mechanism and antioxidant intervention strategies. Chem Biol Interact Huang Z, Yang L, Chu Y, Yu H, Fu X, Liu M, Du X, Wang L, Zhang H. PMID: 42276319 [PubMed - as supplied by publisher]
	A Clinical Decision Support System to Optimize Antimicrobial Dosing in Patients with Renal Impairment. Appl Clin Inform Garcia-Souto A, Ibáñez-García S, Torroba-Sanz B, Domínguez-Chaparro G, Nuñez-Nuñez M, Velasco-Carcía ME, de la Rosa-Triviño JL, Herranz-Alonso A, Sanjurjo-Sáez M. PMID: 42276146 [PubMed - as supplied by publisher]
	UK prostate cancer screening trial to include more Black men. Lancet Oncol Gourd E. PMID: 42276089 [PubMed - as supplied by publisher]
	Anticoagulation in end-stage renal disease. Thromb Res D'Angelo M, Mavrakanas TA. PMID: 42275706 [PubMed - as supplied by publisher]
	Developmental Programming of Human Kidney Function. Annu Rev Cell Dev Biol McMahon AP. PMID: 42275611 [PubMed - as supplied by publisher]
	Clonal Hematopoiesis of Indeterminate Potential and Kidney Failure in Chronic Kidney Disease: An East Asian Cohort Study. Clin J Am Soc Nephrol Kim M, An S, Ryu H, Sun C, An HY, Ryu G, Kim J, Kim Y, Kim SW, Kim YH, Jaiswal S, Koh Y, Oh KH. PMID: 42275156 [PubMed - as supplied by publisher]
	Cross-Species Comparison between Mouse Kidney Multi-Omics and Human Genome-Wide Association Studies Highlights Molecular Features Associated with Oxalate Nephropathy. Kidney360 Chaya R, Taguchi K, Hashimoto Y, Shirai Y, Edahiro R, Sasa N, Yamamoto K, Tomofuji Y, Namba S, Sonehara K, Unno R, Hamamoto S, Okada A, Muroski J, Kato Y, Cristea IM, Okada Y, Yasui T. PMID: 42275142 [PubMed - as supplied by publisher]
	Prostate Imaging Standards for Screening Magnetic Resonance Imaging (PRISM): International Consensus Recommendations. JAMA Oncol Mayor N, Light A, Gopalakrishnan A, Cullen E, Rawlins F, Sonigra-Patel V, Thorley N, Barrett T, Bratt O, Dudderidge T, Emberton M, Giganti F, Haider A, Haider MA, Hulson O, Lakhani A, Moore C, Nordstrom T, Padhani AR, Schoots IG, Smith A, Tam H, Valerio M, Verma S, Withey SJ, Punwani S, Shah TT, van der Meulen J, Ahmed HU. PMID: 42275039 [PubMed - as supplied by publisher]

Articles 1 - 20 / 473817

Page 1 of 23691



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy